Korean sibutramine generics increase market share

Korean-made sibutramine preparations are increasing their market share in the first half of this year, an industry report showed recently.

According to global healthcare research firm IMS Health, Hanmi Pharm recorded 6.5 billion from this year’s first-half sales of Slimmer, followed by Chong Kun Dang P...